imipramine has been researched along with 1,3-ditolylguanidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, T; Kurahashi, N; Miwa, T; Nishi, T; Oshiro, Y; Sakurai, Y; Sato, S; Tanaka, T; Tottori, K; Uwahodo, Y | 1 |
| Börgel, F; Catapano, CV; Civenni, G; Friedland, K; Holtschulte, C; Humpf, HU; Kopp, N; Laurini, E; Lehmkuhl, K; Pricl, S; Schepmann, D; Wünsch, B | 1 |
| Nishikawa, T; Shirayama, Y; Takahashi, K; Umino, A | 1 |
3 other study(ies) available for imipramine and 1,3-ditolylguanidine
| Article | Year |
|---|---|
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
Topics: Animals; Antidepressive Agents; Brain Concussion; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred ICR; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, sigma; Structure-Activity Relationship | 2000 |
Novel σ
Topics: Amination; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclohexanes; Humans; Male; Mice; Prostatic Neoplasms; Receptors, sigma; Sigma-1 Receptor; Structure-Activity Relationship | 2021 |
p-chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain.
Topics: Animals; Biogenic Monoamines; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Desipramine; Fenclonine; Fluoxetine; Guanidines; Hippocampus; Imipramine; Kinetics; Male; Proteins; Rats; Rats, Wistar; Receptors, sigma; Serotonin | 1993 |